Cargando…
A cancer therapeutic nanoparticle vaccine targeting HAAH improves 3-week survival from 12.5% to 100% in a mouse model of metastatic breast cancer
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288663/ http://dx.doi.org/10.1186/2051-1426-2-S3-P52 |
| _version_ | 1782352006123356160 |
|---|---|
| author | Fuller, Steven Lebowitz, Michael S Stewart, Solomon Ghanbari, Hossein A |
| author_facet | Fuller, Steven Lebowitz, Michael S Stewart, Solomon Ghanbari, Hossein A |
| author_sort | Fuller, Steven |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4288663 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-42886632015-01-15 A cancer therapeutic nanoparticle vaccine targeting HAAH improves 3-week survival from 12.5% to 100% in a mouse model of metastatic breast cancer Fuller, Steven Lebowitz, Michael S Stewart, Solomon Ghanbari, Hossein A J Immunother Cancer Poster Presentation BioMed Central 2014-11-06 /pmc/articles/PMC4288663/ http://dx.doi.org/10.1186/2051-1426-2-S3-P52 Text en Copyright © 2014 Fuller et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Fuller, Steven Lebowitz, Michael S Stewart, Solomon Ghanbari, Hossein A A cancer therapeutic nanoparticle vaccine targeting HAAH improves 3-week survival from 12.5% to 100% in a mouse model of metastatic breast cancer |
| title | A cancer therapeutic nanoparticle vaccine targeting HAAH improves 3-week survival from 12.5% to 100% in a mouse model of metastatic breast cancer |
| title_full | A cancer therapeutic nanoparticle vaccine targeting HAAH improves 3-week survival from 12.5% to 100% in a mouse model of metastatic breast cancer |
| title_fullStr | A cancer therapeutic nanoparticle vaccine targeting HAAH improves 3-week survival from 12.5% to 100% in a mouse model of metastatic breast cancer |
| title_full_unstemmed | A cancer therapeutic nanoparticle vaccine targeting HAAH improves 3-week survival from 12.5% to 100% in a mouse model of metastatic breast cancer |
| title_short | A cancer therapeutic nanoparticle vaccine targeting HAAH improves 3-week survival from 12.5% to 100% in a mouse model of metastatic breast cancer |
| title_sort | cancer therapeutic nanoparticle vaccine targeting haah improves 3-week survival from 12.5% to 100% in a mouse model of metastatic breast cancer |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288663/ http://dx.doi.org/10.1186/2051-1426-2-S3-P52 |
| work_keys_str_mv | AT fullersteven acancertherapeuticnanoparticlevaccinetargetinghaahimproves3weeksurvivalfrom125to100inamousemodelofmetastaticbreastcancer AT lebowitzmichaels acancertherapeuticnanoparticlevaccinetargetinghaahimproves3weeksurvivalfrom125to100inamousemodelofmetastaticbreastcancer AT stewartsolomon acancertherapeuticnanoparticlevaccinetargetinghaahimproves3weeksurvivalfrom125to100inamousemodelofmetastaticbreastcancer AT ghanbarihosseina acancertherapeuticnanoparticlevaccinetargetinghaahimproves3weeksurvivalfrom125to100inamousemodelofmetastaticbreastcancer AT fullersteven cancertherapeuticnanoparticlevaccinetargetinghaahimproves3weeksurvivalfrom125to100inamousemodelofmetastaticbreastcancer AT lebowitzmichaels cancertherapeuticnanoparticlevaccinetargetinghaahimproves3weeksurvivalfrom125to100inamousemodelofmetastaticbreastcancer AT stewartsolomon cancertherapeuticnanoparticlevaccinetargetinghaahimproves3weeksurvivalfrom125to100inamousemodelofmetastaticbreastcancer AT ghanbarihosseina cancertherapeuticnanoparticlevaccinetargetinghaahimproves3weeksurvivalfrom125to100inamousemodelofmetastaticbreastcancer |